These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9380485)

  • 1. ACTOBAT: 1-year follow-up.
    Paneth N
    Pediatrics; 1997 Nov; 100(5):903-4. PubMed ID: 9380485
    [No Abstract]   [Full Text] [Related]  

  • 2. The credibility of the ACTOBAT follow-up study.
    McCormick MC
    Pediatrics; 1997 Mar; 99(3):476-8. PubMed ID: 9041308
    [No Abstract]   [Full Text] [Related]  

  • 3. The ACTOBAT debate.
    Crowther C
    Pediatrics; 1997 Sep; 100(3 Pt 1):418-9. PubMed ID: 9304109
    [No Abstract]   [Full Text] [Related]  

  • 4. Australian Collaborative Trial of Antenatal Thyrotropin-Releasing Hormone: adverse effects at 12-month follow-up. ACTOBAT Study Group.
    Crowther CA; Hiller JE; Haslam RR; Robinson JS
    Pediatrics; 1997 Mar; 99(3):311-7. PubMed ID: 9041281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyrotropin-releasing hormone for prevention of neonatal respiratory disease.
    Ballard RA; Ballard PL; Cnaan A; Pinto-Martin J
    Lancet; 1995 Jun; 345(8964):1572. PubMed ID: 7791458
    [No Abstract]   [Full Text] [Related]  

  • 6. [Does prenatal administration of thyrotropin releasing hormone contribute to premature delivery?].
    Binder T; Kopecký P; Plavka R; Sebron V; Zlatohlávková B; Svihovec P; Zivný J
    Ceska Gynekol; 1999 Jan; 64(1):10-9. PubMed ID: 10377584
    [No Abstract]   [Full Text] [Related]  

  • 7. Antenatal lung maturation--should we all be using thyrotropin-releasing hormone?
    Fisk NM; Peek MJ
    Eur J Pediatr; 1995; 154(8 Suppl 3):S7-9. PubMed ID: 7588988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is maternal thyrotropin releasing hormone administration safe in the pregnant woman with preeclampsia?
    Tan AS; Hsu CD; Marder S; Copel JA
    Am J Perinatol; 1997 Jan; 14(1):5-6. PubMed ID: 9259888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antenatal thyrotropin-releasing hormone to prevent lung disease in preterm infants. North American Thyrotropin-Releasing Hormone Study Group.
    Ballard RA; Ballard PL; Cnaan A; Pinto-Martin J; Davis DJ; Padbury JF; Phibbs RH; Parer JT; Hart MC; Mannino FL; Sawai SK
    N Engl J Med; 1998 Feb; 338(8):493-8. PubMed ID: 9468465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Australian collaborative trial of antenatal thyrotropin-releasing hormone (ACTOBAT) for prevention of neonatal respiratory disease.
    Lancet; 1995 Apr; 345(8954):877-82. PubMed ID: 7707809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenatal treatment with thyrotrophin releasing hormone to prevent neonatal respiratory distress.
    de Zegher F; Spitz B; Devlieger H
    Arch Dis Child; 1992 Apr; 67(4 Spec No):450-4. PubMed ID: 1316739
    [No Abstract]   [Full Text] [Related]  

  • 12. Thyrotropin-releasing hormone added to corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease.
    Crowther CA; Alfirevic Z; Haslam RR
    Cochrane Database Syst Rev; 2004; (2):CD000019. PubMed ID: 15106139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antenatal TRH.
    Chiswick M
    Lancet; 1995 Apr; 345(8954):872-3. PubMed ID: 7707804
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prenatal lung maturation with corticosteroids--an overview].
    Hildebrand K; Hösli I; Holzgreve W
    Z Geburtshilfe Neonatol; 1996; 200(6):207-12. PubMed ID: 9081746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyrotropin-releasing hormone for prevention of neonatal respiratory disease.
    Moya FR; Maturana A
    Lancet; 1995 Jun; 345(8964):1572-3. PubMed ID: 7646688
    [No Abstract]   [Full Text] [Related]  

  • 16. Controversies in antenatal corticosteroid treatment.
    Klinger G; Koren G
    Can Fam Physician; 2000 Aug; 46():1571-3. PubMed ID: 10955173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fetal lung maturation: the combined use of corticosteroids and thyrotropin-releasing hormone.
    Morales WJ; O'Brien WF; Angel JL; Knuppel RA; Sawai S
    Obstet Gynecol; 1989 Jan; 73(1):111-6. PubMed ID: 2491766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prenatal prevention of infant respiratory distress syndrome. 2nd part: clinical applications and indications].
    Lenclen R; Paupe A; Philippe HJ; Olivier-Martin M; Nisand I
    J Gynecol Obstet Biol Reprod (Paris); 1995; 24(3):294-309. PubMed ID: 7622778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Administration of glucocorticosteroids to premature infants: increasing evidence of adverse effects].
    van Bel F
    Ned Tijdschr Geneeskd; 2001 Dec; 145(52):2521-5. PubMed ID: 11793826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychological development of children who were treated antenatally with corticosteroids to prevent respiratory distress syndrome.
    Schmand B; Neuvel J; Smolders-de Haas H; Hoeks J; Treffers PE; Koppe JG
    Pediatrics; 1990 Jul; 86(1):58-64. PubMed ID: 2193303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.